Gara Jalqabaatti › Myelofibrosis › Florida › Miami
Qorannoo klinikaalii Myelofibrosis Miami, FL keessatti
Qorannoo 10 Myelofibrosis f Miami fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Namoota walitti qabaa jiraSadarkaa 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Namoota walitti qabaa jiraSadarkaa 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Namoota walitti qabaa jiraSadarkaa 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Namoota walitti qabaa jiraSadarkaa 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Namoota walitti qabaa jiraSadarkaa 3
- University of Miami, Miami
Qorannoo Myelofibrosis magaalota biroo keessatti
- Houston, TXQorannoo 19
- New York City, NYQorannoo 18
- Durham, NCQorannoo 12
- Boston, MAQorannoo 12
- Columbus, OHQorannoo 11
- Seattle, WAQorannoo 11
- Salt Lake City, UTQorannoo 10
- Tampa, FLQorannoo 9
- Nashville, TNQorannoo 9
- Atlanta, GAQorannoo 9
- Cleveland, OHQorannoo 9
- Baldwin Park, CAQorannoo 9
Qorannoo biroo Miami keessatti
- Saree OljooQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 36
- Kansara Qara'a Non-Small CellQorannoo 31
- Kansarii ProstateQorannoo 27
- ObesityQorannoo 27
- Leukemia Myeloidii HamaaQorannoo 24
- Kansara MetastatikiiQorannoo 24
- Kansarii OvariiQorannoo 23
- Baayyee UlfaataaQorannoo 23
- Myeloma Baay’eeQorannoo 21
- Colitis UlcerativeQorannoo 21
- Dhukkubaa AlzheimerQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.